Literature DB >> 9160516

A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein.

Y Nakamura1, M Kameoka, M Tobiume, M Kaya, K Ohki, T Yamada, K Ikuta.   

Abstract

Cell-mediated immune responses constitute a major defense against the spread of human immunodeficiency virus type 1 (HIV-1). However, multiple alterations within a particular epitope may accumulate during disease progression, allowing the virus to escape cytotoxic T lymphocytes (CTLs). Therefore, the best candidate for a peptide vaccine that would prevent the onset of the disease might be a chain section containing epitopes for the generation of CTLs in regions of conserved sequences among different HIV-1 isolates. We previously showed that immunizing mice with synthetic peptides consisting of 23-amino acids (Gag-23mer; 287-309 amino acid residues) in a highly conserved region derived from the major core protein p24 of HIV-1 generates specific CTLs as well as antibodies. Here, we identified one CTL (T-1; 291-300) and two B-cell (B-1; 290-299 and B-2; 300-309) epitopes, all of which consisted of 10 amino acids within the region. In addition, helper T cells primed by the Gag-23mer peptide were proliferated by in vitro stimulation with a 21mer (H-1; 289-309) or a 19mer (H-2; 291-309) peptide, but not with a 17mer peptide (293-309) or 19mer peptide (287-305). Immunization with the H-1 peptide generated an antibody reactive to B-1, but not B-2, whereas that with H-2 generated an antibody reactive to B-2, but not B-1. CTLs were not generated by immunization with these peptides, indicating that the entire sequence of Gag-23mer is the helper epitope for CTLs. Thus, the Gag-23mer is a chain section containing epitopes for cytotoxic T, B and helper T-cells within a highly conserved region of HIV-1 Gag protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9160516     DOI: 10.1016/s0264-410x(96)00224-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques.

Authors:  P S Polacino; V Stallard; J E Klaniecki; S Pennathur; D C Montefiori; A J Langlois; B A Richardson; W R Morton; R E Benveniste; S L Hu
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Viral replication modulated by synthetic peptide derived from hepatitis B virus X protein.

Authors:  Chang-Zheng Song; Qing-Wei Wang; Chang-Cheng Song; Zeng-Liang Bai
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

3.  HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses.

Authors:  April L Ferre; Peter W Hunt; Delandy H McConnell; Megan M Morris; Juan C Garcia; Richard B Pollard; Hal F Yee; Jeffrey N Martin; Steven G Deeks; Barbara L Shacklett
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

4.  Gag protein epitopes recognized by CD4(+) T-helper lymphocytes from equine infectious anemia virus-infected carrier horses.

Authors:  S M Lonning; W Zhang; T C McGuire
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

5.  Variability and immunogenicity of human immunodeficiency virus type 1 p24 gene quasispecies.

Authors:  J Iroegbu; M Birk; U Lazdina; A Sönnerborg; M Sällberg
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

6.  Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment.

Authors:  U Malhotra; S Holte; S Dutta; M M Berrey; E Delpit; D M Koelle; A Sette; L Corey; M J McElrath
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

7.  Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors.

Authors:  S M Lonning; W Zhang; S R Leib; T C McGuire
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

8.  Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.

Authors:  W Zhang; S M Lonning; T C McGuire
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs.

Authors:  Sinu Paul; Helen Piontkivska
Journal:  BMC Microbiol       Date:  2010-08-09       Impact factor: 3.605

10.  Generating neutralizing antibodies, Th1 response and MHC non restricted immunogenicity of HIV-I env and gag peptides in liposomes and ISCOMs with in-built adjuvanticity.

Authors:  Lokesh Agrawal; W Haq; Carl Veith Hanson; D Nageswara Rao
Journal:  J Immune Based Ther Vaccines       Date:  2003-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.